{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:26:26Z","timestamp":1791199586128,"version":"4.2.0"},"reference-count":0,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"published-print":{"date-parts":[[2010,4,21]]},"DOI":"10.3892\/ijo_00000619","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T09:48:34Z","timestamp":1271843314000},"source":"Crossref","is-referenced-by-count":15,"title":["Noteworthy clinical case studies in cancer gene therapy: Tumor-targeted Rexin-G advances as an efficacious anti-cancer agent"],"prefix":"10.3892","volume":"36","author":[{"family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","container-title":["International Journal of Oncology"],"original-title":[],"link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo_00000619\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T09:39:03Z","timestamp":1493285943000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/ijo\/36\/6\/1341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,21]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4,21]]}},"URL":"https:\/\/doi.org\/10.3892\/ijo_00000619","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,21]]}}}